Oliver Werz

19.2k total citations · 1 hit paper
450 papers, 15.0k citations indexed

About

Oliver Werz is a scholar working on Pharmacology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Oliver Werz has authored 450 papers receiving a total of 15.0k indexed citations (citations by other indexed papers that have themselves been cited), including 192 papers in Pharmacology, 169 papers in Molecular Biology and 94 papers in Organic Chemistry. Recurrent topics in Oliver Werz's work include Inflammatory mediators and NSAID effects (120 papers), Estrogen and related hormone effects (54 papers) and Asthma and respiratory diseases (49 papers). Oliver Werz is often cited by papers focused on Inflammatory mediators and NSAID effects (120 papers), Estrogen and related hormone effects (54 papers) and Asthma and respiratory diseases (49 papers). Oliver Werz collaborates with scholars based in Germany, Italy and Austria. Oliver Werz's co-authors include Dieter Steinhilber, Andreas Koeberle, Olof Rådmark, Bengt Samuelsson, Carlo Pergola, Hinnak Northoff, Manfred Schubert‐Zsilavecz, Lidia Sautebin, Jana Gerstmeier and Antonietta Rossi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Oliver Werz

436 papers receiving 14.7k citations

Hit Papers

5-Lipoxygenase, a key enzyme for leukotriene biosynthesis... 2014 2026 2018 2022 2014 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease
    2014 401 citations Oliver Werz et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oliver Werz Germany 63 5.7k 5.1k 2.9k 1.8k 1.7k 450 15.0k
Dieter Steinhilber Germany 49 3.9k 0.7× 2.2k 0.4× 1.6k 0.6× 1.5k 0.9× 1.3k 0.7× 296 9.6k
Chinthalapally V. Rao United States 62 6.4k 1.1× 3.8k 0.8× 1.0k 0.4× 783 0.4× 789 0.5× 262 16.9k
Vladimı́r Křen Czechia 53 8.5k 1.5× 1.9k 0.4× 2.6k 0.9× 982 0.6× 1.5k 0.9× 539 14.7k
Hartmut Kühn Germany 67 6.1k 1.1× 2.0k 0.4× 1.9k 0.6× 2.5k 1.4× 1.9k 1.1× 322 13.9k
David L. DeWitt United States 59 4.8k 0.8× 9.1k 1.8× 1.5k 0.5× 1.7k 1.0× 1.6k 0.9× 109 17.4k
Che‐Ming Teng Taiwan 64 7.6k 1.3× 2.5k 0.5× 3.3k 1.1× 892 0.5× 1.1k 0.7× 489 16.0k
Thomas E. Eling United States 67 5.7k 1.0× 3.5k 0.7× 1.4k 0.5× 2.3k 1.3× 2.9k 1.7× 294 15.0k
Young‐Joon Surh South Korea 81 14.7k 2.6× 3.2k 0.6× 1.8k 0.6× 2.4k 1.4× 1.9k 1.1× 411 27.8k
Jaime L. Masferrer United States 56 4.1k 0.7× 9.7k 1.9× 2.5k 0.9× 1.2k 0.7× 2.3k 1.3× 135 17.9k
Colin Funk United States 65 6.8k 1.2× 4.7k 0.9× 1.4k 0.5× 3.7k 2.1× 3.2k 1.8× 183 17.6k

Countries citing papers authored by Oliver Werz

Since Specialization
Citations

This map shows the geographic impact of Oliver Werz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Werz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Werz more than expected).

Fields of papers citing papers by Oliver Werz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Werz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Werz. The network helps show where Oliver Werz may publish in the future.

Co-authorship network of co-authors of Oliver Werz

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Werz. A scholar is included among the top collaborators of Oliver Werz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Werz. Oliver Werz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gutjahr, Caroline, H.P. Engelbrecht, Dana Kralisch, et al.. (2025). Ginsenosides from Panax ginseng modulate lipid mediator profiles in human leukocytes by interference with cellular 5-lipoxygenase activity. Biochemical Pharmacology. 236. 116882–116882.
3.
Olğaç, Abdurrahman, Paul M. Jordan, Christian Kretzer, Oliver Werz, & Erden Banoğlu. (2025). Discovery of novel microsomal prostaglandin E2 synthase 1 (mPGES-1) inhibitors by a structurally inspired virtual screening study. Journal of Molecular Graphics and Modelling. 136. 108962–108962.
4.
Jordan, Paul M., et al.. (2025). 2‐Phenylbenzothiazoles featuring heteroaryl sulfonamide end‐capping substructures as developable mPGES‐1 inhibitors. Archiv der Pharmazie. 358(1). e2400756–e2400756. 1 indexed citations
5.
Deng, Yun, Veit Grabe, Thomas Sommermann, et al.. (2024). Bacteria modulate microalgal aging physiology through the induction of extracellular vesicle production to remove harmful metabolites. Nature Microbiology. 9(9). 2356–2368. 11 indexed citations
6.
Vollrath, Antje, David Pretzel, Paul M. Jordan, et al.. (2024). PEG–Lipid–PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs. Pharmaceutics. 16(2). 187–187. 8 indexed citations
7.
Jordan, Paul M., et al.. (2024). The Fatal Mushroom Neurotoxin Muscarine is Released from a Harmless Phosphorylated Precursor upon Cellular Injury. Angewandte Chemie International Edition. 63(52). e202417220–e202417220. 3 indexed citations
8.
Klemm, Paul, Steffi Stumpf, Paul M. Jordan, et al.. (2023). Ethoxy acetalated dextran nanoparticles for drug delivery: A comparative study of formulation methods. International Journal of Pharmaceutics X. 5. 100173–100173. 13 indexed citations
9.
10.
Hebecker, Betty, Paul M. Jordan, Oliver Werz, et al.. (2023). Establishment and Characterization of Mild Atopic Dermatitis in the DNCB-Induced Mouse Model. International Journal of Molecular Sciences. 24(15). 12325–12325. 34 indexed citations
11.
Kretzer, Christian, et al.. (2023). Label-Free Characterization of Macrophage Polarization Using Raman Spectroscopy. International Journal of Molecular Sciences. 24(1). 824–824. 13 indexed citations
12.
13.
Olğaç, Abdurrahman, et al.. (2023). Substituted 1,2,4-Triazoles as Novel and Selective Inhibitors of Leukotriene Biosynthesis Targeting 5-Lipoxygenase-Activating Protein. ACS Omega. 8(34). 31293–31304. 2 indexed citations
14.
Jordan, Paul M., et al.. (2023). Differential impact of 5-lipoxygenase-activating protein antagonists on the biosynthesis of leukotrienes and of specialized pro-resolving mediators. Frontiers in Pharmacology. 14. 1219160–1219160. 14 indexed citations
15.
Cai, Yi, et al.. (2021). Mitochondrial Fusion Mediated by Mitofusin 1 Regulates Macrophage Mycobactericidal Activity by Enhancing Autophagy. Infection and Immunity. 89(11). e0030621–e0030621. 18 indexed citations
16.
Bartel, Karin, Helmut Pein, Bastian Popper, et al.. (2019). Connecting lysosomes and mitochondria – a novel role for lipid metabolism in cancer cell death. Cell Communication and Signaling. 17(1). 87–87. 34 indexed citations
17.
Pace, Simona, et al.. (2019). Myxochelin- and Pseudochelin-Derived Lipoxygenase Inhibitors from a Genetically Engineered Myxococcus xanthus Strain. Journal of Natural Products. 82(9). 2544–2549. 24 indexed citations
18.
Dawczynski, Christine, Thomas Neumann, Katharina Goetze, et al.. (2017). Docosahexaenoic acid in the treatment of rheumatoid arthritis: A double-blind, placebo-controlled, randomized cross-over study with microalgae vs. sunflower oil. Clinical Nutrition. 37(2). 494–504. 76 indexed citations
19.
Maess, M, Ulrike Garscha, Christina Weinigel, et al.. (2015). A procedure for efficient non-viral siRNA transfection of primary human monocytes using nucleofection. Journal of Immunological Methods. 422. 118–124. 9 indexed citations
20.
Müller, H. W., et al.. (2015). Synthesis and biological evaluation of novel myrtucommulones and structural analogues that target mPGES-1 and 5-lipoxygenase. European Journal of Medicinal Chemistry. 101. 133–149. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dieter Steinhilber Breakdown of academic impact, for papers by Chinthalapally V. Rao Breakdown of academic impact, for papers by Vladimı́r Křen Breakdown of academic impact, for papers by Hartmut Kühn Breakdown of academic impact, for papers by David L. DeWitt Breakdown of academic impact, for papers by Che‐Ming Teng Breakdown of academic impact, for papers by Thomas E. Eling Breakdown of academic impact, for papers by Young‐Joon Surh Breakdown of academic impact, for papers by Jaime L. Masferrer Breakdown of academic impact, for papers by Colin Funk
Rankless by CCL
2026